We are live on
!
Find out more
NGM
North Growth Management Portfolio holdings
AUM
$780M
1-Year Est. Return
102.77%
This Fund
S&P 500
This Quarter
Est. Return
+13.8%
1 Year Est. Return
+102.77%
3 Year Est. Return
+230.6%
5 Year Est. Return
+253.58%
10 Year Est. Return
–
AUM
$602M
AUM Growth
+$34.5M
(+6.1%)
Cap. Flow
-$23M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
41.13%
Holding
57
New
7
Increased
8
Reduced
10
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global Payments
GPN
|
+$10.1M |
| 2 |
Revvity
RVTY
|
+$9.22M |
| 3 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$9.12M |
| 4 |
Tapestry
TPR
|
+$7.11M |
| 5 |
Abercrombie & Fitch
ANF
|
+$7.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$9.93M |
| 2 |
MillerKnoll
MLKN
|
+$9.14M |
| 3 |
American Eagle Outfitters
AEO
|
+$7.87M |
| 4 |
CERN
Cerner Corp
CERN
|
+$7.82M |
| 5 |
Itron
ITRI
|
+$7.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 46.24% |
| 2 | Consumer Discretionary | 23.1% |
| 3 | Healthcare | 14.84% |
| 4 | Industrials | 11.46% |
| 5 | Communication Services | 4.35% |
Similar funds
PCM
SAM
QCM
AC
ABWM
HI
LTI
MAM
North Growth Management's Q4 2021 Portfolio in Review
As of Q4 2021, North Growth Management held 57 positions worth $602M, up 6.1% from $567M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
North Growth Management withdrew a net $23M in Q4 2021, closing 8 positions and reducing 10 holdings. Its most notable exit was Gilead Sciences, an estimated $9.93M position sold in full.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 45% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, North Growth Management opened a new position in Global Payments worth $9.82M.
- North Growth Management's largest Q4 2021 buy was Global Payments: 73,000 shares worth $9.82M.
- North Growth Management added most to Tapestry in Q4 2021, an estimated $7.11M increase.
- North Growth Management's biggest Q4 2021 reduction was Itron, cutting an estimated $7.6M.
- North Growth Management fully exited Gilead Sciences in Q4 2021, selling an estimated $9.93M.
- North Growth Management's ten largest holdings make up 41% of its $602M portfolio in Q4 2021.
- North Growth Management opened 7 new positions and closed 8 in Q4 2021.
- North Growth Management's portfolio value rose 6.1% quarter-over-quarter to $602M.
Based on North Growth Management's 13F filing for Q4 2021, filed 7 Feb 2022.